Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances

Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: September 07, 2026

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Journal: Oral oncology

Published: September 04, 2026

Tissue-Informed ctDNA Assay Performance in Head and Neck Squamous Cell Carcinoma.

Journal: JAMA otolaryngology-- head & neck surgery

Published: September 03, 2026

Immunotherapy in head and neck squamous cell carcinoma: oncologic and functional outcomes.

Journal: Current opinion in otolaryngology & head and neck surgery

Published: September 01, 2026

Culture-positive neck abscess masking metastatic squamous cell carcinoma: a diagnostic pitfall.

Journal: BMJ case reports

Published: August 28, 2026

Corrigendum to "Matched-pair analysis of the outcome of two different neck dissection techniques for oral squamous cell carcinoma" [J Stomatol Oral Maxillofac Surg 127 (2026) 102937].

Journal: Journal of stomatology, oral and maxillofacial surgery

Published: August 28, 2026

Diagnostic performance of the proposed DECT NI-RADS criteria for imaging surveillance of post-treatment head and neck squamous cell carcinoma: A preliminary study.

Journal: The neuroradiology journal

Published: August 26, 2026

RhoA wild-type allele loss unleashes the cancer driver function of RhoA E40Q.

Journal: The Journal of clinical investigation

Published: August 25, 2026

Ras homolog family member A expression is associated with reduced cetuximab sensitivity in head and neck squamous cell carcinoma.

Journal: The Journal of international medical research

Published: August 24, 2026

Methodological concerns regarding "PD-L1 cutoff selection and predictive claims in the IT-MATTERS Trial".

Journal: Oral oncology

Published: August 21, 2026

Integrating minimal residual disease into postoperative treatment selection for head and neck cancer.

Journal: Oral oncology

Published: August 20, 2026

ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: August 20, 2026

Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances

Find the Latest Research About Head and Neck Squamous Cell Carcinoma (HNSCC)

Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment

Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Tissue-Informed ctDNA Assay Performance in Head and Neck Squamous Cell Carcinoma.

Tissue-Informed ctDNA Assay Performance in Head and Neck Squamous Cell Carcinoma.

Immunotherapy in head and neck squamous cell carcinoma: oncologic and functional outcomes.

Immunotherapy in head and neck squamous cell carcinoma: oncologic and functional outcomes.

Culture-positive neck abscess masking metastatic squamous cell carcinoma: a diagnostic pitfall.

Culture-positive neck abscess masking metastatic squamous cell carcinoma: a diagnostic pitfall.

Corrigendum to "Matched-pair analysis of the outcome of two different neck dissection techniques for oral squamous cell carcinoma" [J Stomatol Oral Maxillofac Surg 127 (2026) 102937].

Corrigendum to "Matched-pair analysis of the outcome of two different neck dissection techniques for oral squamous cell carcinoma" [J Stomatol Oral Maxillofac Surg 127 (2026) 102937].

Diagnostic performance of the proposed DECT NI-RADS criteria for imaging surveillance of post-treatment head and neck squamous cell carcinoma: A preliminary study.

Diagnostic performance of the proposed DECT NI-RADS criteria for imaging surveillance of post-treatment head and neck squamous cell carcinoma: A preliminary study.

RhoA wild-type allele loss unleashes the cancer driver function of RhoA E40Q.

RhoA wild-type allele loss unleashes the cancer driver function of RhoA E40Q.

Ras homolog family member A expression is associated with reduced cetuximab sensitivity in head and neck squamous cell carcinoma.

Ras homolog family member A expression is associated with reduced cetuximab sensitivity in head and neck squamous cell carcinoma.

Methodological concerns regarding "PD-L1 cutoff selection and predictive claims in the IT-MATTERS Trial".

Methodological concerns regarding "PD-L1 cutoff selection and predictive claims in the IT-MATTERS Trial".

Integrating minimal residual disease into postoperative treatment selection for head and neck cancer.

Integrating minimal residual disease into postoperative treatment selection for head and neck cancer.

ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.

ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.